• 18q Deletion Syndrome Presenting with Late-Onset Combined Immunodeficiency
• A case of biopsy-proven acute interstitial nephritis following atezolizumab-bevacizumab treatment of advanced unresectable hepatocellular carcinoma
• A combined immune and inflammatory indicator predict the prognosis of severe Pneumocystis jirovecii pneumonia patients: a 12-year, retrospective, observational cohort
• A rare case of pneumocystosis under anti-PD-L1 therapy
• A retrospective Italian analysis on the characteristics of invasive fungal infections in the intensive care unit setting: CHARTER-IFI study
• An Unusual Case of Pneumocystis jirovecii Cystic Pneumonia
• Anti-Synthetase Syndrome: A Case Report on the Elevated Risk of Pneumocystosis
• Application of metagenomic next-generation sequencing and targeted metagenomic next-generation sequencing in diagnosing pulmonary infections in immunocompetent and immunocompromised patients
• Breakthrough Pneumocystis jirovecii Pneumonia in an Allogeneic Hematopoietic Stem Cell Transplant Recipient
• Causal relationship between type 1 diabetes mellitus and mycoses: a Mendelian randomization study
• Challenges in optimizing the treatment of Pneumocystis pneumonia in the intensive care unit
• Challenges in optimizing the treatment of Pneumocystis pneumonia in the intensive care unit. Author's reply
• Changes in the Mortality Rate and Epidemiology of Pneumocystis Pneumonia Require Novel Approaches to Clinical Care
• Clinical and Radiological Features of Pneumocystis jirovecii Pneumonia in Children: A Case Series
• Clinical Characteristics and Epidemiological Analysis of Pneumocystis Jirovecii Pneumonia Infection in Kidney Transplant Patients with Trimethoprim-Sulfamethoxazole Dose Reduction Prophylaxis Strategy
• Clinical Characteristics and Prognosis of Patients With Severe Pneumonia With Pneumocystis jirovecii Colonization: A Multicenter, Retrospective Study
• Clinical Characteristics and Prognostic Predictors of Pneumocystis Jirovecii Pneumonia in Patients with and without Chronic Pulmonary Disease: A Retrospective Cohort Study
• Clinical course and prognostic factors of Pneumocystis pneumonia with respiratory failure in non-HIV patients
• Clinical features and death risk factors of pneumocystis jirovecii pneumonia in kidney disease patients with immunosuppressive therapy
• Coinfection of Cytomegalovirus, Pneumocystis jirovecii pneumonia, COVID-19, and Mycobacterium colombiense in an AIDS patient: A case report
• Critical Considerations for PCR Diagnostics in Pneumocystis Pneumonia Detection
• Current perspective on infections and mitigation strategies in primary systemic vasculitis
• Cutaneous Pneumocystis Jirovecii Infection in an Allogeneic Stem Cell Transplant Recipient
• Dapsone-Induced Methemoglobinemia in a Woman With Multiple Myeloma Without Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency
• Deep mutational scanning of Pneumocystis jirovecii dihydrofolate reductase reveals allosteric mechanism of resistance to an antifolate
• Description of a Murine Model of Pneumocystis Pneumonia
• Designing an mRNA Vaccine against P. jirovecii Involved in Fatal Pneumonia Infections via Comparative Proteomics and Reverse Vaccinology Approaches
• Diagnostic Challenge for Positive 1,3-β-D-Glucan in an Immunocompromised Patient Receiving Intravenous Immunoglobulin Presenting With Respiratory Failure
• Diagnostic Performance of the (1-3)-beta-D-glucan Assay in Patients with Different Risks for Invasive Fungal Diseases
• Diagnostic performance of the (1-3)-β-d-glucan assay in patients with different risks for invasive fungal diseases
• Efficacy and safety of carrimycin in ten patients with severe pneumonia following solid organ transplantation
• Elevated serum lactate dehydrogenase aids prediction of mortality in Pneumocystis jirovecii pneumonia without underlying human immunodeficiency virus infection - Derivation of a clinical risk score
• Features and global impact of invasive fungal infections caused by Pneumocystis jirovecii: A systematic review to inform the World Health Organization fungal priority pathogens list
• Frequency of infections during rituximab treatment of autoimmune blistering diseases
• Haploidentical Hematopoietic Stem Cell Transplantation for Paediatric Patients with X-linked Lymphoproliferative Syndrome
• Identification of predictive markers of Pneumocystis jirovecii pneumonia in kidney transplant recipients
• Immune checkpoint inhibitor increased mortality in lung cancer patients with Pneumocystis jirovecii pneumonia: a comparative retrospective cohort study
• Impact of Sulfonamide Allergy Label on Clinical Outcomes in Patients with Pneumocystis jirovecii Pneumonia
• Incidence, characteristics and survival of patients with pneumocystis pneumonia in solid oncology
• Infection prophylaxis among patients with antineutrophil cytoplasmic antibody (ANCA) vasculitis: a scoping review
• Insights into copper sensing and tolerance in Pneumocystis species
• Integrated analysis of microbiome and host transcriptome unveils correlations between lung microbiota and host immunity in bronchoalveolar lavage fluid of pneumocystis pneumonia patients
• Interpretation of results of PCR and B-D-glucan for the diagnosis of Pneumocystis Jirovecii Pneumonia in immunocompromised adults with acute respiratory failure
• Lessons from Multiple Infections Such as Lymphoma Complicated with Pneumocystis Infection: A Case Report
• Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections: A Review
• Lymphomatoid granulomatosis mimicking PJP infection
• Mapping the Burden of Fungal Diseases in the United Arab Emirates
• Metagenomic Next-Generation Sequencing for Accurate Diagnosis of Pneumocystis jirovecii Pneumonia: A Comparative Study with Traditional Methods
• Metagenomic next-generation sequencing promotes diagnosis and treatment of Pneumocystis jirovecii pneumonia in non-HIV infected children: a retrospective study
• Miliary Pneumocystis jiroveci pneumonia in a patient living with HIV
• Misdiagnosis Diagnosis of Pneumocystis Pneumonia as Chemical Pneumonitis
• Non-HIV Immunocompetent Patient with COVID-19 and Severe Pneumocystis jirovecii Pneumonia Co-Infection
• Opportunistic Infections, Mortality Risk, and Prevention Strategies in Patients With Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome
• Outcome of Pneumocystis pneumonia in transplant and non-transplant HIV-negative immunocompromised patients
• PCR diagnosis of Pneumocystis pneumonia
• Perception of pneumocystis jirovecii pneumonia (PJP) prophylaxis in glioma patients receiving concurrent temozolomide and radiation- a patient and physician survey
• Pneumocystis jirovecii in human disease: just pneumonia?
• Pneumocystis jirovecii Pneumonia Complicated by Pneumomediastinum: A Case Report
• Pneumocystis jirovecii Pneumonia in a Liver Transplant Recipient With an Adverse Reaction to Trimethoprim/Sulfamethoxazole Treated With a Sulfonamide Desensitization Protocol: Case Report
• Pneumocystis jirovecii Pneumonia in HIV-Negative, Non-transplant Patients: Epidemiology, Clinical Manifestations, Diagnosis, Treatment, and Prevention
• Pneumocystis jirovecii pneumonia in non-HIV patients: need for a more extended prophylaxis
• Pneumocystis jirovecii Pneumonia Prophylaxis in Patients with ANCA Vasculitis on Rituximab Maintenance Therapy
• Pneumocystis murina lesions in lungs of experimentally infected Cd40l(-/-) mice
• Pneumocystis murina promotes inflammasome formation and NETosis during Pneumocystis pneumonia
• Pneumocystis pneumonia in Cushing's syndrome
• Pneumocystis pneumonia in French intensive care units in 2013-2019: mortality and immunocompromised conditions
• Pneumocystis pneumonia in intensive care: clinical spectrum, prophylaxis patterns, antibiotic treatment delay impact, and role of corticosteroids. A French multicentre prospective cohort study
• Pneumocystis Pneumonia Presenting With Peripheral Predominant Consolidation and Traction Bronchiectasis
• Pneumothorax as a Prelude: Unveiling Concurrent HIV and Pneumocystis jirovecii Pneumonia in a Diagnostic Journey
• Polymerase Chain Reaction on Respiratory Tract Specimens of Immunocompromised Patients to Diagnose Pneumocystis Pneumonia: A Systematic Review and Meta-analysis
• Population Pharmacokinetics of Trimethoprim/Sulfamethoxazole: Dosage Optimization for Patients with Renal Insufficiency or Receiving Continuous Renal Replacement Therapy
• Preclinical and Toxicology Assessment of ALW-II-41-27, an Inhibitor of the Eph Receptor A2 (EphA2)
• Predictive models-assisted diagnosis of AIDS-associated Pneumocystis jirovecii pneumonia in the emergency room, based on clinical, laboratory, and radiological data
• Presumptive Cytomegalovirus Retinitis as a Complication of Dyskeratosis Congenita: A Case Report
• Prevalence and Causes of Vitamin D Deficiency in a Cohort of Greek HIV-Infected Individuals: A Prospective, Single Center, Observational Study
• Prognostic Factors of In-hospital Mortality in Patients without Human Immunodeficiency Virus Infection with Pneumocystis Pneumonia: A Retrospective Cohort Study
• Progressive Lung Consolidation in HIV Amidst the COVID-19 Pandemic: Evaluating Probable Cytomegalovirus Pneumonia and the Importance of Early Empirical Treatment
• Prone positioning does not improve outcomes of intubated patients with pneumocystis pneumonia and moderate-severe acute respiratory distress syndrome: a single-center, retrospective, observational, cohort study
• Protocol for the systematic review of the Pneumocystis jirovecii-associated pneumonia in non-HIV immunocompromised patients
• Rapid Diagnosis of Pneumocystis jirovecii Pneumonia and Respiratory Tract Colonization by Next-Generation Sequencing
• Refractory granulomatous Pneumocystis jirovecii pneumonia masquerading as malignancy
• Response to correspondence on Pneumocystis pneumonia in Cushing's syndrome
• Risk factors and multi-pathogen infections in kidney transplant recipients with omicron variant pneumonia: a retrospective analysis
• Risk factors for Pneumocystis jirovecii pneumonia after kidney transplantation: A systematic review and meta-analysis
• Risk of Invasive Fungal Infections in Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors: A Case-Control Propensity Score-Matched Analysis
• Safety of Dapsone for Pneumocystis Jiroveci Pneumonia Prophylaxis in Patients With Multiple Myeloma
• Severe Pneumocystis jirovecii pneumonia: time to reassess our practices
• Should we reconsider Pneumocystis pneumonia presentation and treatment according to its underlying disease? An unsupervised cluster analysis of a retrospective multicentre study
• Should We Reconsider Pneumocystis Pneumonia Presentation and Treatment According to Its Underlying Disease?: An Unsupervised Cluster Analysis of a Retrospective Multicenter Study
• Spontaneous Pneumothorax, Pneumomediastinum, and Pneumopericardium in an HIV Patient With Tuberculosis: A Rare Trio
• Successful maintenance treatment of disseminated nocardiosis with cerebral abscess in a severely immunocompromised patient allergic to trimethoprim-sulfamethoxazole using moxifloxacin and high-dose minocycline: A case report
• Sulfamethoxazole-Trimethoprim Prophylaxis in Pediatric Oncology Patients With Glucose-6-Phosphate Dehydrogenase Deficiency
• Sulfonamide allergy label and the risk of opportunistic infections in solid organ transplant recipients - A retrospective matched cohort study
• The Brief Case: False-negative Pneumocystis PCR
• The role of systemic corticosteroids when treating infections in adult primary care
• Trichosporon asahii co-infection with Pneumocystis jiroveci in a renal transplant patient
• Trimethoprim-sulfamethoxazole combined with echinocandins versus trimethoprim-sulfamethoxazole alone for Pneumocystis pneumonia in patients without human immunodeficiency virus infection: A nationwide retrospective cohort study
• Unified metagenomic method for rapid detection of microorganisms in clinical samples
• Variance in Pneumocystis jirovecii prophylaxis practice for pediatric patients undergoing hematopoietic cell transplantation
• X-linked Inhibitor of Apoptosis (XIAP) Deficiency Complicated by Hemophagocytic Lymphohistiocytosis on Immunotherapy Leading to Acute Respiratory Distress Syndrome and Multiorgan Failure Secondary to Opportunistic Infections